Published in Crit Rev Oncol Hematol on December 31, 2009
The complex pathophysiology of acquired aplastic anaemia. Clin Exp Immunol (2015) 0.91
IFN-γ causes aplastic anemia by altering hematopoietic stem/progenitor cell composition and disrupting lineage differentiation. Blood (2014) 0.88
Differential gene expression profile associated with the abnormality of bone marrow mesenchymal stem cells in aplastic anemia. PLoS One (2012) 0.83
Mesenchymal stem cells in immune-mediated bone marrow failure syndromes. Clin Dev Immunol (2013) 0.81
Bone marrow mesenchymal stem cells from patients with aplastic anemia maintain functional and immune properties and do not contribute to the pathogenesis of the disease. Haematologica (2014) 0.81
Inflammation as a Driver of Clonal Evolution in Myeloproliferative Neoplasm. Mediators Inflamm (2015) 0.79
Impaired immunomodulatory ability of bone marrow mesenchymal stem cells on CD4(+) T cells in aplastic anemia. Results Immunol (2012) 0.79
The role of RIP1 and RIP3 in the development of aplastic anemia induced by cyclophosphamide and busulphan in mice. Int J Clin Exp Pathol (2014) 0.75
Enhanced adipogenicity of bone marrow mesenchymal stem cells in aplastic anemia. Stem Cells Int (2014) 0.75
In patients with chronic aplastic anemia, bone marrow-derived MSCs regulate the Treg/Th17 balance by influencing the Notch/RBP-J/FOXP3/RORγt pathway. Sci Rep (2017) 0.75
Genetic associations in acquired immune-mediated bone marrow failure syndromes: insights in aplastic anemia and chronic idiopathic neutropenia. Clin Dev Immunol (2012) 0.75
Polymorphisms of the TGF-β1 gene and the risk of acquired aplastic anemia in a Chinese population. Ann Hematol (2016) 0.75
CD106 is a novel mediator of bone marrow mesenchymal stem cells via NF-κB in the bone marrow failure of acquired aplastic anemia. Stem Cell Res Ther (2017) 0.75
Autologous transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells improves critical limb ischemia in diabetes. Diabetes Care (2005) 2.11
Bone marrow stromal cells transduced with human hemangiopoietin gene support hematopoiesis in vitro. Haematologica (2005) 2.03
Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura. Haematologica (2005) 1.75
Proliferation and differentiation of bone marrow stromal cells under hypoxic conditions. Biochem Biophys Res Commun (2006) 1.72
STAT3: a critical transcription activator in angiogenesis. Med Res Rev (2008) 1.69
Therapeutic potential of human umbilical cord derived stem cells in a rat myocardial infarction model. Ann Thorac Surg (2007) 1.57
Abnormality of CD4(+)CD25(+) regulatory T cells in idiopathic thrombocytopenic purpura. Eur J Haematol (2007) 1.50
Short-term ex vivo expansion sustains the homing-related properties of umbilical cord blood hematopoietic stem and progenitor cells. Haematologica (2004) 1.46
Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism. Clin Immunol (2010) 1.37
Cross-talk between the VEGF-A and HGF signalling pathways in endothelial cells. Biol Cell (2009) 1.28
Enhancement of neovascularization with cord blood CD133+ cell-derived endothelial progenitor cell transplantation. Thromb Haemost (2004) 1.26
Peroxisome proliferator-activated receptor gamma in malignant diseases. Crit Rev Oncol Hematol (2006) 1.21
HGF receptor up-regulation contributes to the angiogenic phenotype of human endothelial cells and promotes angiogenesis in vitro. Blood (2003) 1.20
Safety of mesenchymal stem cells for clinical application. Stem Cells Int (2012) 1.20
In vitro and in vivo differentiation of human umbilical cord derived stem cells into endothelial cells. J Cell Biochem (2007) 1.19
MicroRNA-124 suppresses breast cancer cell growth and motility by targeting CD151. Cell Physiol Biochem (2013) 1.17
Therapeutic effect of human umbilical cord multipotent mesenchymal stromal cells in a rat model of stroke. Transplantation (2009) 1.16
Oxidized low density lipoprotein impairs endothelial progenitor cells by regulation of endothelial nitric oxide synthase. J Lipid Res (2006) 1.14
Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Front Med (2011) 1.13
CD106 identifies a subpopulation of mesenchymal stem cells with unique immunomodulatory properties. PLoS One (2013) 1.13
Hemangiopoietin, a novel human growth factor for the primitive cells of both hematopoietic and endothelial cell lineages. Blood (2004) 1.11
Differentiation of human umbilical cord mesenchymal stromal cells into low immunogenic hepatocyte-like cells. Cytotherapy (2009) 1.11
Angiogenesis and antiangiogenic therapy in hematologic malignancies. Crit Rev Oncol Hematol (2006) 1.09
Stem cell engraftment and survival in the ischemic heart. Ann Thorac Surg (2011) 1.09
Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord, and placenta: implication in the migration. Proteomics (2009) 1.08
Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis. Cell Transplant (2011) 1.08
Intrapulmonary delivery of human umbilical cord mesenchymal stem cells attenuates acute lung injury by expanding CD4+CD25+ Forkhead Boxp3 (FOXP3)+ regulatory T cells and balancing anti- and pro-inflammatory factors. Cell Physiol Biochem (2011) 1.08
Randomised comparison of G-CSF-mobilized peripheral blood mononuclear cells versus bone marrow-mononuclear cells for the treatment of patients with lower limb arteriosclerosis obliterans. Thromb Haemost (2007) 1.05
Therapeutic benefit of human umbilical cord derived mesenchymal stromal cells in intracerebral hemorrhage rat: implications of anti-inflammation and angiogenesis. Cell Physiol Biochem (2009) 1.04
Kinetic expression of platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) during embryonic stem cell differentiation. J Cell Biochem (2005) 1.02
Mesenchymal stem cells: biology and clinical potential in type 1 diabetes therapy. J Cell Mol Med (2008) 0.99
Intraspinal transplantation of CD34+ human umbilical cord blood cells after spinal cord hemisection injury improves functional recovery in adult rats. Cell Transplant (2004) 0.98
Transplantation of umbilical cord blood-derived endothelial progenitor cells: a promising method of therapeutic revascularisation. Eur J Haematol (2006) 0.97
Granulocyte colony-stimulating factor reduces cardiomyocyte apoptosis and improves cardiac function in adriamycin-induced cardiomyopathy in rats. Cardiovasc Drugs Ther (2006) 0.96
Multi-dysfunctional pathophysiology in ITP. Crit Rev Oncol Hematol (2005) 0.94
Characterization and neural differentiation of fetal lung mesenchymal stem cells. Cell Transplant (2005) 0.94
Mesenchymal stem cells ameliorate experimental autoimmune uveoretinitis by comprehensive modulation of systemic autoimmunity. Invest Ophthalmol Vis Sci (2011) 0.92
Roles of platelet factor 4 in hematopoiesis and angiogenesis. Growth Factors (2006) 0.92
Cell delivery in cardiac regenerative therapy. Ageing Res Rev (2011) 0.92
Immunomodulatory effects of mesenchymal stem cells in a rat corneal allograft rejection model. Exp Eye Res (2012) 0.91
Cellular therapy and myocardial tissue engineering: the role of adult stem and progenitor cells. Eur J Cardiothorac Surg (2006) 0.91
Survivin and leukemia. Int J Hematol (2004) 0.90
Comparison of cell-suspension and explant culture of rabbit limbal epithelial cells. Exp Eye Res (2005) 0.90
No contribution of umbilical cord mesenchymal stromal cells to capillarization and venularization of hepatic sinusoids accompanied by hepatic differentiation in carbon tetrachloride-induced mouse liver fibrosis. Cytotherapy (2010) 0.90
Interleukin-27 upregulates major histocompatibility complex class II expression in primary human endothelial cells through induction of major histocompatibility complex class II transactivator. Hum Immunol (2007) 0.89
Interferon-gamma +874A/T and interleukin-4 intron3 VNTR gene polymorphisms in Chinese patients with idiopathic thrombocytopenic purpura. Eur J Haematol (2007) 0.89
Transcriptional regulation of survivin by c-Myc in BCR/ABL-transformed cells: implications in anti-leukaemic strategy. J Cell Mol Med (2009) 0.89
Autologous transplantation of peripheral blood stem cells as an effective therapeutic approach for severe arteriosclerosis obliterans of lower extremities. Thromb Haemost (2004) 0.89
Cardiac potential of stem cells from whole human umbilical cord tissue. J Cell Biochem (2009) 0.89
CD14+ monocytes promote the immunosuppressive effect of human umbilical cord matrix stem cells. Exp Cell Res (2010) 0.88
Impaired therapeutic vasculogenesis by transplantation of OxLDL-treated endothelial progenitor cells. J Lipid Res (2006) 0.88
The role of Th17 cells in adult patients with chronic idiopathic thrombocytopenic purpura. Eur J Haematol (2009) 0.88
Regulation of the class II and class I MHC pathways in human THP-1 monocytic cells by interleukin-27. Biochem Biophys Res Commun (2008) 0.87
Hemangiopoietin inhibits apoptosis of MO7e leukemia cells through phosphatidylinositol 3-kinase-AKT pathway. Biochem Biophys Res Commun (2004) 0.86
Neuropilin-1 in acute myeloid leukemia: expression and role in proliferation and migration of leukemia cells. Leuk Lymphoma (2008) 0.86
Mesenchymal stem cells support proliferation and terminal differentiation of B cells. Cell Physiol Biochem (2012) 0.85
Therapeutic neovascularization by transplantation of mobilized peripheral blood mononuclear cells for limb ischemia. A comparison between CD34+ and CD34- mononuclear cells. Thromb Haemost (2006) 0.84
Serum-free media and the immunoregulatory properties of mesenchymal stem cells in vivo and in vitro. Cell Physiol Biochem (2014) 0.84
Human multipotent mesenchymal stromal cells from fetal lung expressing pluripotent markers and differentiating into cell types of three germ layers. Cell Transplant (2009) 0.83
A toxicity study of multiple-administration human umbilical cord mesenchymal stem cells in cynomolgus monkeys. Stem Cells Dev (2011) 0.83
Differential gene expression profile associated with the abnormality of bone marrow mesenchymal stem cells in aplastic anemia. PLoS One (2012) 0.83
Leukemia stem cells. Int J Hematol (2006) 0.83
An effective and simple expansion system for megakaryocyte progenitor cells using a combination of heparin with thrombopoietin and interleukin-11. Exp Hematol (2005) 0.82
Cyclin D1 gene polymorphism and susceptibility to childhood acute lymphoblastic leukemia in a Chinese population. Int J Hematol (2005) 0.82
Mesenchymal stem/stromal cells (MSC) transfected with stromal derived factor 1 (SDF-1) for therapeutic neovascularization: enhancement of cell recruitment and entrapment. Med Hypotheses (2007) 0.82
Adenovirus-mediated gene therapy with an antiangiogenic fragment of thrombospondin-1 inhibits human leukemia xenograft growth in nude mice. Leuk Res (2003) 0.82
Statins, nitric oxide and neovascularization. Cardiovasc Drug Rev (2005) 0.82
Suppression of tumor growth by viral vector-mediated gene transfer of N-terminal truncated platelet factor 4. Cancer Biother Radiopharm (2003) 0.82
Early down-regulation of Bcl-xL expression during megakaryocytic differentiation of thrombopoietin-induced CD34+ bone marrow cells in essential thrombocythemia. Haematologica (2004) 0.81
Retracted Comparative proteomic analysis of mesenchymal stem cells derived from human bone marrow, umbilical cord and placenta: implication in the migration. Adv Exp Med Biol (2011) 0.81
HI44a, an anti-CD44 monoclonal antibody, induces differentiation and apoptosis of human acute myeloid leukemia cells. Leuk Res (2004) 0.80
Polymorphisms in ERCC1 and susceptibility to childhood acute lymphoblastic leukemia in a Chinese population. Leuk Res (2006) 0.80
Endothelial progenitor cells transfected with PDGF: cellular and molecular targets for prevention of diabetic microangiopathy. Med Hypotheses (2006) 0.80
Human umbilical cord derived stem cells for the injured heart. Med Hypotheses (2006) 0.80
Signal transduction of chemokine platelet factor 4 in human erythroleukemia cells. Int J Hematol (2002) 0.80
Treatment of acute promyelocytic leukemia and other hematologic malignancies with arsenic trioxide: review of clinical and basic studies. Int J Hematol (2003) 0.79
Mesenchymal stem cells from bone marrow show a stronger stimulating effect on megakaryocyte progenitor expansion than those from non-hematopoietic tissues. Platelets (2010) 0.79
Transient pancytopenia preceding T lineage acute lymphoblastic leukemia. Acta Haematol (2004) 0.79
Cardiac cell therapy: pre-conditioning effects in cell-delivery strategies. Cytotherapy (2011) 0.78
Elevated plasma levels of vascular endothelial growth factor is associated with marked splenomegaly in chronic myeloid leukemia. Leuk Lymphoma (2005) 0.78
Reversal of P-glycoprotein-mediated multidrug resistance with small interference RNA (siRNA) in leukemia cells. Cancer Gene Ther (2004) 0.78
Inhibition of K562 leukemia angiogenesis and growth by expression of antisense vascular endothelial growth factor (VEGF) sequence. Cancer Gene Ther (2003) 0.78
Transplantation of Human Placenta-Derived Mesenchymal Stem Cells Alleviates Critical Limb Ischemia in Diabetic Nude Rats. Cell Transplant (2016) 0.77
Stem cells for tissue engineering of myocardial constructs. Ageing Res Rev (2007) 0.77
Human mesenchymal stem cells possess different biological characteristics but do not change their therapeutic potential when cultured in serum free medium. Stem Cell Res Ther (2014) 0.77
Hemangiopoietin supports animal survival and accelerates hematopoietic recovery of chemotherapy-suppressed mice. Eur J Haematol (2007) 0.77
IL-6 production stimulated by CD14(+) monocytes-paracrined IL-1β does not contribute to the immunosuppressive activity of human umbilical cord mesenchymal stem cells. Cell Physiol Biochem (2012) 0.77
Platelet factor 4 enhances the adhesion of normal and leukemic hematopoietic stem/progenitor cells to endothelial cells. Leuk Res (2004) 0.77
Exogenous Nanog alleviates but is insufficient to reverse embryonic stem cells differentiation induced by PI3K signaling inhibition. J Cell Biochem (2009) 0.76
Production of a monoclonal antibody against SARS-CoV spike protein with single intrasplenic immunization of plasmid DNA. Immunol Lett (2005) 0.76
Enhancement of neovascularization with mobilized blood cells transplantaion: supply of angioblasts and angiogenic cytokines. J Cell Biochem (2007) 0.76
Splenectomy for adult chronic idiopathic thrombocytopenic purpura: experience from a single center in China. Eur J Haematol (2005) 0.76
Angiogenesis in hematologic malignancies and its clinical implications. Int J Hematol (2002) 0.76
No association of the plasminogen activator inhibitor-1 promoter 4G/5G polymorphism with inhibitor level during basal transcription in vitro. Int J Hematol (2004) 0.75
[Effect of fetal lung mesenchymal stem cells on differentiation of umbilical cord blood mononuclear cells into megakaryocytes]. Zhongguo Shi Yan Xue Ye Xue Za Zhi (2009) 0.75
Live attenuated Salmonella carrying platelet factor 4 cDNAs as radioprotectors. Radiat Res (2006) 0.75
Erratum to: Comparative Proteomic Analysis of Mesenchymal Stem Cells Derived from Human Bone Marrow, Umbilical Cord and Placenta: Implication in the Migration. Adv Exp Med Biol (2012) 0.75
Leptin enhances in vitro secretion of IgG antiplatelet antibodies by splenocytes and peripheral blood mononuclear cells from patients with chronic idiopathic thrombocytopenic purpura. Clin Immunol (2006) 0.75
Serum leptin levels in patients with idiopathic thrombocytopenic purpura. Eur J Haematol (2004) 0.75
Effects of human umbilical cord-derived mesenchymal stem cells on anterior chamber-associated immune deviation. Int Immunopharmacol (2012) 0.75